Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Testosterone affects androgen receptors and lipid storage in cells, while DHEA does not convert to testosterone or affect these receptors in the same way.

Finasteride is a safe and effective long-term treatment for prostate enlargement, reducing prostate volume and related symptoms.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Dihydrotestosterone (DHT) increases oil production in skin cells by activating mTOR, and mTOR inhibitors can reduce this effect.

Certain drugs that block specific enzymes can help treat prostate diseases.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

Dihydrotestosterone gel before hypospadias surgery led to less scarring but raised concerns about potential psychological effects and skin changes.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Finasteride changes androgen receptor location in rat epididymis without altering tissue structure.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Finasteride treatment makes the prostate look more like a healthy one.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

The method effectively measures drug impact on DHT levels in prostate treatments.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Finasteride effectively reduces DHT and E2 levels, helping with prostate enlargement.

Finasteride and dutasteride may cause macular abnormalities.

In 2005, men used finasteride mainly to treat an enlarged prostate.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.